However, in 2008, Sauter et al. introduced a model where repeated i.p. injections of sub-lethal doses of Stx2 led to the manifestation of HUS-typical symptoms in C57BL/6J mice (33). This evidence concerns the gene STX2 and hemolytic-uremic syndrome.